In vivo and in vitro efficacy of capecitabine (X) in combination with hormone therapies for breast cancer (BC)

被引：0
|
作者：
Mori, Kazushige
Yamaguchi, Yuri
Sawada, Noriaki
Kondoh, Kumiko
Hayashi, Shin-ichi
机构：
[1] Chugai Pharmaceut Co Ltd, Prod Res, Kamakura, Kanagawa, Japan
[2] Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama 362, Japan
[3] Tohoku Univ, Sch Med, Course Hlth Sci, Sendai, Miyagi 980, Japan
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] In vivo and in vitro efficacy of capecitabine (X) plus tamoxifen (TAM) in breast cancer (BC)
    Mori, K.
    Yamaguchi, Y.
    Sawada, N.
    Kondoh, K.
    Hayashi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Safety and Efficacy of Oral Vinorelbine and Capecitabine Combination for Metastatic Breast Cancer
    Di Seri, M.
    De Sanctis, R.
    Quadrini, S.
    Adua, D.
    Stumbo, L.
    Del Signore, E.
    Gori, B.
    Grassi, P.
    Basile, M. L.
    Longo, F.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (02) : 110 - 113
  • [3] Efficacy of neoadjuvant bevacizumab (Av), capecitabine (X), and docetaxel (T) for invasive breast cancer (BC): Phase II result
    Greil, R.
    Moik, M.
    Reitsamer, R.
    Ressler, S.
    Stoll, M.
    Namberger, K.
    Menzel, C.
    Mlineritsch, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE
    Del Signore, E.
    Quadrini, S.
    De Sanctis, R.
    Stumbo, L.
    Gori, B.
    Recine, F.
    Adua, D.
    Basile, M. L.
    Tedeschi, M.
    Lo Russo, V
    Bucco, R.
    Longo, F.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [5] Efficacy and tolerability of capecitabine (X) monotherapy in metastatic breast cancer (MBC)
    Vasev, Nikola
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [6] Performance of capecitabine in novel combination therapies in colorectal cancer
    Pouya, Fahima Danesh
    Rasmi, Yousef
    Camci, Irem Yalim
    Tutar, Yusuf
    Nemati, Mohadeseh
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (06) : 375 - 389
  • [7] Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies
    Verheul, HAM
    Coelingh-Bennink, HJT
    Kenemans, P
    Atsma, WJ
    Burger, CW
    Eden, JA
    Hammar, M
    Marsden, J
    Purdie, DW
    MATURITAS, 2000, 36 (01) : 1 - 17
  • [8] Identifying most promising combination therapies for immune suppressive breast cancer using a combined in vitro/in vivo approach
    Silberzahn, Hannah
    Bleisch, Mattias
    Lohr, Anne
    Knauff, Volker
    Lashuk, Kanstantsin
    Schueler, Julia B.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Efficacy of capecitabine-based combination therapy and singleagent capecitabine maintenance therapy in patients with metastatic breast cancer
    Huimin Lv
    Min Yan
    Mengwei Zhang
    Limin Niu
    Huiai Zeng
    Shude Cui
    ChineseJournalofCancerResearch, 2014, 26 (06) : 692 - 697
  • [10] Capecitabine and docetaxel combination for the treatment of breast cancer
    Morishita, Mariko
    Leonard, Robert C.
    WOMENS HEALTH, 2008, 4 (01) : 11 - 22
12345